Table 3.

Correlations (p values) of the alerted eye movement recording findings with the clinical data

	Altered eye movement recording	Altered smooth pursuit	Prolonged latencies	Altered anti-saccades
Gender	.698	.921	.424	.893
Mean age of onset	.024	.637	.780	.304
Form of onset	.48	.396	.245	.221
Mean disease duration	.948	.789	.384	.879
Clinical findings: Tongue atrophy ALSFRS-R score	.004 .696	.089 .563	.285. 026	.960 .818
Non-motor signs: Sensory symptoms Bladder dysfunction Autonomic dysfunction Cognitive dysfunction Extrapyramidal symptoms	.021 .051 .029 .733 .733 .275	.003 .244 .036 .229 .737 .408	.087 .031 .780 .380 .380 .013	.992 .664 .678 .582 .120 .705
Cognitive assessment: Median MMSE score Altered MMSE score Median FAB score Altered FAB score	.917 .617 .495 .089	.117 .039 .026 .011	.712 .724 .459 .903	.752 .452 .380 .289

ALSFRS-R = Revised amyotrophic lateral sclerosis functional rating scale

FAB = Frontal assessment battery

MMSE = Mini-mental state examination